ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Network pharmacology and pharmacokinetics integrated strategy to investigate the pharmacological mechanism of Xianglian pill on ulcerative colitis

Liu, Chang-Shun*; Xia, Ting; Luo, Zhen-Ye; Wu, Yuan-Yuan; Hu, Yan-Nan; Chen, Fei-Long; Tang, Qing-Fa*; Tan, Xiao-Mei*南方医科大学
PHYTOMEDICINE2021-2DOI: 10.1016/j.phymed.2020.153458
43被引9阅读
引用收藏
分享

摘要

Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with high morbidity, which leads to poor quality of life. The Xianglian pill (XLP) is a classical Chinese patent medicine and has been clinically proven to be an effective treatment for UC. @@@ Purpose: The pharmacological mechanism of the key bioactive ingredients of XLP for the treatment of UC was investigated by a network pharmacology and pharmacokinetics integrated strategy. @@@ Study design and methods: Network pharmacology was used to analyze the treatment effect of nine quantified XLP ingredients on UC. Key pathways were enriched and analyzed by protein-protein interaction and Kyoto Encyclopedia of Genes and Genomes analyses. The effect of XLP on Th17 cell differentiation was validated using a mouse model of UC. The binding of nine compounds with JAk2, STAT3, HIF-1 alpha, and HSP90AB1 was assessed using molecular docking. A simple and reliable ultra-high-performance liquid chromatography-tandem mass spectrometry method was developed for the simultaneous quantification of nine ingredients from XLP in plasma and applied to a pharmacokinetic study following oral administration. @@@ Results: Nine compounds of XLP, including coptisine, berberine, magnoflorine,berberrubine, jatrorrhizine, palmatine, evodiamine, rutaecarpine, and dehydrocostus lactone, were detected. Network pharmacology revealed 50 crossover genes between the nine compoundsand UC. XLP treats UC mainly by regulating key pathways of the immune system, including Th17 cell differentiation, Jak-Stat, and PI3K-Akt signaling pathways. An in vivo validation in mice found that XLP inhibits Th17 cell differentiation by suppressing the Jak2-Stat3 pathway, which alleviates mucosal inflammation in UC. Molecular docking confirmed that eight compounds are capable of binding with JAk2, HIF-1 alpha, and HSP90AB1, further confirming the inhibitory effect of XLP on the Jak2-Stat3 pathway. Moreover, apharmacokinetic study revealed that the nine ingredients of XLP are exposed in the plasma and colon tissue, which demonstrates its pharmacological effect on UC. @@@ Conclusion: This study evaluates the clinical treatment efficacy of XLP for UC. The network pharmacology and pharmacokinetics integrated strategy evaluation paradigm is efficient in discovering the key pharmacological mechanism of herbal formulae.

学科与关键词

关键词
Xianglian pillUlcerative colitisNetwork pharmacologyPharmacokineticsIntegrated strategyMolecular docking
相关
加载中…
  • Bioactive Components and Potential Mechanism Prediction of Kui Jie Kang against Ulcerative Colitis via Systematic Pharmacology and UPLC-QE-MS Analysis
    He, Jinbiao; Wan, Chunping; Li, Xiaosi; Zhang, Zishu; Yang, Yu; Wang, Huaning; Qi, Yan*Evidence-based Complementary and Alternative Medicine, 2022, 2022: 9122315.被引 1
  • Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis
    Yang, Yuanming; Hua, Yiwei; Chen, Weihuan; Zheng, Huan; Wu, Haomeng; Qin, Shumin*; Huang, Shaogang*Frontiers in Pharmacology, 2022, 13: 1037856.被引 4
  • Efficacy of active ingredients in Qingdai (Indigo Naturalis) on ulcerative colitis: a network pharmacology-based evaluation
    Li, Yue; Wen, Shuting; Zhao, Runyuan; Fan, Dongmei; Zhao, Dike; Liu, Fengbin; Mi, Hong*Journal of Traditional Chinese Medicine, 2023, 43(1): 124-133.
查看全部 →

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2021-02
卷期
第 82 卷
页码
153458
DOI
10.1016/j.phymed.2020.153458
语言
GERMAN
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
China Postdoctoral Science Foundation [2019TQ0140, 2019M663013]; Basic and Applied Basic Research Fund Project of Guangdong Province [2019A1515110600]

作者

  • L

    Liu, Chang-Shun (通讯) (第一作者)

    southern med univ

  • X

    Xia, Ting

    southern med univ

查看全部 8 位作者收起作者
  • L

    Luo, Zhen-Ye

    southern med univ

  • W

    Wu, Yuan-Yuan

    southern med univ

  • H

    Hu, Yan-Nan

    southern med univ

  • C

    Chen, Fei-Long

    southern med univ

  • T

    Tang, Qing-Fa (通讯)

    southern med univ

  • T

    Tan, Xiao-Mei (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417